Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of “Moderate Buy” by Analysts

Henry Schein, Inc. (NASDAQ:HSIC) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $81.10.

A number of equities research analysts have recently weighed in on HSIC shares. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Hedge Funds Weigh In On Henry Schein

Several institutional investors and hedge funds have recently added to or reduced their stakes in HSIC. Pathstone Holdings LLC raised its position in Henry Schein by 3.1% during the 3rd quarter. Pathstone Holdings LLC now owns 24,028 shares of the company’s stock worth $1,752,000 after purchasing an additional 732 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Henry Schein by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after acquiring an additional 6,184 shares during the last quarter. Cerity Partners LLC lifted its stake in shares of Henry Schein by 12.3% in the third quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock worth $1,920,000 after acquiring an additional 2,894 shares during the period. Daiwa Securities Group Inc. boosted its holdings in Henry Schein by 11.4% in the third quarter. Daiwa Securities Group Inc. now owns 15,636 shares of the company’s stock valued at $1,140,000 after acquiring an additional 1,596 shares during the last quarter. Finally, Bank of Montreal Can increased its position in Henry Schein by 365.6% during the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after purchasing an additional 558,689 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Up 0.3 %

Henry Schein stock opened at $69.25 on Thursday. The company’s 50-day moving average price is $74.31 and its two-hundred day moving average price is $72.65. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.60 billion, a P/E ratio of 28.50, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business earned $0.66 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. As a group, analysts expect that Henry Schein will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.